ArticleInternational journal of cancer2012

Efficacy of anti-insulin-like growth factor I receptor monoclonal antibody cixutumumab in mesothelioma is highly correlated with insulin growth factor-I receptor sites/cell.

Neetu Kalra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.